Synexa Life Sciences expands operations in North America with new Rockville laboratory siteNew site supports unique and seamless workflows that narrow the gap between preclinical and clinical phasesJune 13, 2022
Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilitiesExpansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals.May 19, 2022
Synexa Life Sciences announces strategic growth plans and strengthening of its executive teamDelivering on growth strategies to become the global market leader in specialist biomarker and bioanalytical services.May 18, 2022
Synexa Life Sciences Co-founder and CEO to become company’s ChairmanLeading biomarker and bioanalysis company lays the foundation for future growth and expansion plan.May 13, 2022
Synexa Announces Tripartite CollaborationTogether with Paraxel and Drawbridge Health, Synexa offers a streamlined solution to COVID-19 serology testing.March 23, 2021
